0001437749-24-009808.txt : 20240430 0001437749-24-009808.hdr.sgml : 20240430 20240328155708 ACCESSION NUMBER: 0001437749-24-009808 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioCardia, Inc. CENTRAL INDEX KEY: 0000925741 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 232753988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 320 SOQUEL WAY CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 650-226-0123 MAIL ADDRESS: STREET 1: 320 SOQUEL WAY CITY: SUNNYVALE STATE: CA ZIP: 94085 FORMER COMPANY: FORMER CONFORMED NAME: Tiger X Medical, Inc. DATE OF NAME CHANGE: 20110616 FORMER COMPANY: FORMER CONFORMED NAME: Cardo Medical, Inc. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: CLICKNSETTLE COM INC DATE OF NAME CHANGE: 20000823 CORRESP 1 filename1.htm bcda20240328_corresp.htm

 

BioCardia, Inc.

320 Soquel Way

Sunnyvale, California 94085

 

 

March 28, 2024

 

Via EDGAR

 

U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE

Washington, D.C. 20549-3561

 

Re: BioCardia, Inc.
  Registration Statement on Form S-3
  Filed February 14, 2024
  File No. 333-277059
   
  Acceleration Request
  Requested Date: April 1, 2024
  Requested Time: 4:30 p.m. Eastern Time

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-277059) (the “Registration Statement”), be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff of the Securities and Exchange Commission.

 

The Company hereby authorizes Austin March of Wilson Sonsini Goodrich & Rosati, P.C., counsel for the Company, to make such request on the Company’s behalf.

 

The Company requests that it be notified of the effectiveness of the Registration Statement by contacting Austin March at (512) 338-5410 or amarch@wsgr.com.

 

 

 

Sincerely,

 

 

 

BIOCARDIA, INC.
   
 

By:

 /s/ David McClung

 

  

David McClung

Chief Financial Officer

 

 

cc: Peter Altman, BioCardia, Inc.
  Austin March, Esq., Wilson Sonsini Goodrich & Rosati, P.C.